PANKAJ R PATEL

'Investment of Rs 3K-5K cr needed to create extra mfg facilities for COVID-19 vaccine'

"... If India has to produce and deliver 130 crore doses to Indian people in one year time, my opinion is that India would need to invest in manufacturing facilities to the extent of roughly Rs 3,000 to Rs 5,000 crore to create additional capacity to make it happen," Patel said.

More in PANKAJ R PATEL

Zydus Cadila inks pact with Medicines Patent Pool for Hepatitis C drug

"We are happy to work together with the Medicines Patent Pool and Bristol-Myers Squibb to serve the cause of healthcare by providing access to new and affordable therapies to the economically disadvantaged communities across the developing countries," Zydus group Chairman and MD Pankaj R Patel said.
Zydus ties up with US-based research centre NIAD to develop vaccine

Pharmaceuticals major Zydus today said that its R&D subsidiary Etna Biotech will collaborate with US-based National Institute of Allergy and Infectious Diseases (NIAD) to develop a vaccine against visceral leishmaniasis (VL), known as Kala-Azar in India.